Stock Information
Ascendis Pharma A/S (ASND)
Ticker Symbol: ASND
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $14,006.75 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -3.7369
Revenue (TTM): $11.77 M
Dividend Yield: N/A%
ROE: -257.14%
Latest News
-
Transcript : Ascendis Pharma A/S, Q1 2026 Earnings Call, May 07, 2026
Thu, May 7, 2026 3:05 PM
-
Ascendis Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2026
Thu, May 7, 2026 1:06 PM
-
Ascendis Pharma Q1 Adj. EPS $0.32 Beats $0.21 Estimate, Sales $288.770M Miss $318.050M Estimate
Thu, May 7, 2026 7:56 AM
-
Ascendis Pharma Reports First Quarter 2026 Financial Results
Thu, May 7, 2026 7:31 AM
-
New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years
Wed, May 6, 2026 4:01 PM
Key Financials
Financial data not available
